BIO.News Newsletter

It’s Election Day—we got expert insights on which races are worth staying up late to watch tonight. Plus, BIO joined a letter on an R&D tax change and Avalere released a new report (with support from BIO) on the need for out-of-pocket “smoothing.” (793 words, 3 minutes, 57 seconds)

Before all of our attention turns to tomorrow’s midterms, let’s take a moment for the planet—here’s what you need to know about COP27, and why even the health care sector needs to care about climate change. (728 words, 3 minutes, 38 seconds)

We have the winners of BIO’s Impact Awards and California Life Sciences’ Pantheon Awards. Plus, today’s the 30th anniversary of the 340B program, so we look at how the program has ballooned beyond its original intent. (558 words, 2 minutes, 47 seconds)

The IP waiver for COVID-19 technology was never about access to vaccines, says one BIO expert. Plus, with genetics and digital technology, Bayer is making corn with shorter stalks—we tell you why that’s a good thing. (595 words, 2 minutes, 58 seconds)

A study identifies the potential for systemic racism in health technology assessments. Plus, one BIO member company is expanding its beauty empire with a synbio beauty secret. (507 words, 2 minutes, 32 seconds)

The new episode of the I am BIO Podcast explains why psychedelics aren't just for hippies, and USDA economists explain why we need agricultural biotech. Plus, it's officially Rachel King's first day as BIO's new interim CEO and we have the exclusive story. (693 words, 3 minutes, 27 seconds)

It’s Halloween—and we have scary news about not one, not two, but three viruses circulating in the U.S. Plus, more takeaways from BIO’s Patient and Health Advocacy Summit on the need to center patients, what’s ahead in state legislatures, and engaging with CMS. (710 words, 3 minutes, 33 seconds)

Every member of the Council of State Bioscience Associations (CSBA) joined a letter expressing concerns about expanding the COVID IP waiver, and Mexico’s Deputy Ag Minister confirmed the corn ban is happening. Plus, three takeaways from Day 1 of the Patient and Health Advocacy Summit and how to follow the conversations today. (894 words, 4 minutes, 28 seconds)

We’re at the BIO Patient and Health Advocacy Summit in Washington, D.C., this week, where our team will bring you news and highlights right here and at Bio.News—keep reading to learn how you can follow along and why the patient voice matters, plus, some almost positive news on climate. (543 words, 2 minutes, 42 seconds)

Two reports you need to know about today. First, a new report released by BIO and CSBA with TEConomy finds the U.S. biotech industry is a major economic driver in all 50 states and explores why investment is booming. Second, WHO released the first-ever list of fungal priority pathogens, with 19 fungi we need to pay attention to. (552 words, 2 minutes, 45 seconds)